RYTM
RHYTHM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$91.89
+6.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 35.34x
- P/S forward
- 13.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 31.61x
- Price / sales
- 22.69x
- Price / cash flow
- -77.90x
Enterprise value
- Enterprise value
- $6.2B
- EV / sales
- 21.97x
- EV / EBITDA
- -35.60x
- EV / EBIT
- -32.94x
- Market cap
- $6.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026